Drug Shortage Report for MILRINONE LACTATE INJECTION, USP
| Report ID | 208900 |
| Drug Identification Number | 02244622 |
| Brand name | MILRINONE LACTATE INJECTION, USP |
| Common or Proper name | MILRINONE LACTATE INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | MILRINONE |
| Strength(s) | 1MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 20 mL |
| ATC code | C01CE |
| ATC description | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-11-01 |
| Estimated end date | 2024-04-22 |
| Actual end date | 2024-04-22 |
| Shortage status | Resolved |
| Updated date | 2024-04-23 |
| Company comments | Fresenius Kabi Canada regrets to advise that due to production delays, we will be encountering a supply interruption on our Milrinone Lactate Injection 1 mg/mL SD Vial 20 mL effective November 1, 2023, until April 22, 2024. During this time, our Milrinone Lactate Injection 1 mg/mL SD Vial 10 mL is available for substitution. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v11 | 2024-04-23 | English | Compare |
| v10 | 2024-04-22 | French | Compare |
| v9 | 2024-04-22 | English | Compare |
| v8 | 2024-03-19 | French | Compare |
| v7 | 2024-03-19 | English | Compare |
| v6 | 2024-01-09 | French | Compare |
| v5 | 2024-01-09 | French | Compare |
| v4 | 2024-01-09 | English | Compare |
| v3 | 2023-11-02 | English | Compare |
| v2 | 2023-11-01 | French | Compare |
| v1 | 2023-11-01 | English | Compare |
Showing 1 to 11 of 11